Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study.
Lee JW, Sicre de Fontbrune F, Wong Lee Lee L, Pessoa V, Gualandro S, Füreder W, Ptushkin V, Rottinghaus ST, Volles L, Shafner L, Aguzzi R, Pradhan R, Schrezenmeier H, Hill A. Lee JW, et al. Among authors: gualandro s. Blood. 2019 Feb 7;133(6):530-539. doi: 10.1182/blood-2018-09-876136. Epub 2018 Dec 3. Blood. 2019. PMID: 30510080 Free PMC article. Clinical Trial.
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP. Ataga KI, et al. Among authors: gualandro s. N Engl J Med. 2017 Feb 2;376(5):429-439. doi: 10.1056/NEJMoa1611770. Epub 2016 Dec 3. N Engl J Med. 2017. PMID: 27959701 Free PMC article. Clinical Trial.
Massive autoimmune hemolysis documented by monocyte monolayer assay in a multiply transfused patient using reticulocytes isolated by simple centrifugation in microhematocrit tubes.
Conrado MA, Leão Bonifácio S, Nogueira FM, Saraiva-Filho JCP, Dezan MR, Chinoca KZ, Gomes F, Fonseca GH, Gualandro SFM, Rocha V, Mendrone-Júnior A, Dinardo CL. Conrado MA, et al. Among authors: gualandro sfm. Transfusion. 2018 Jul;58(7):1578-1579. doi: 10.1111/trf.14511. Transfusion. 2018. PMID: 30133821 No abstract available.
Accelerated erythrocyte destruction mimicking post-transfusion hyperhaemolysis in the course of uncomplicated vaso-occlusive crisis associated with sickle cell disease.
Conrado MCAV, Fonseca GSVC, Dezan MR, Mendes FR, Hamasaki DT, Chinoca KZ, Fonseca GH, Gualandro SFM, Rocha V, Mendrone-Júnior A, Dinardo CL. Conrado MCAV, et al. Among authors: gualandro sfm. Transfus Med. 2020 Dec;30(6):522-524. doi: 10.1111/tme.12717. Epub 2020 Sep 18. Transfus Med. 2020. PMID: 32946153 No abstract available.
Impact of HLA-G +3142C>G on the development of antibodies to blood group systems other than the Rh and Kell among sensitized patients with sickle cell disease.
Martins JO, Pagani F, Dezan MR, Oliveira VB, Conrado M, Ziza KC, Gualandro SFM, Langui DM, Bordin JO, Rocha V, Mendrone-Júnior A, Dinardo CL. Martins JO, et al. Among authors: gualandro sfm. Transfus Apher Sci. 2022 Oct;61(5):103447. doi: 10.1016/j.transci.2022.103447. Epub 2022 Apr 27. Transfus Apher Sci. 2022. PMID: 35487873 Clinical Trial.
RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients.
Dezan MR, Ribeiro IH, Oliveira VB, Vieira JB, Gomes FC, Franco LAM, Varuzza L, Ribeiro R, Chinoca KZ, Levi JE, Krieger JE, Pereira AC, Gualandro SFM, Rocha VG, Mendrone-Junior A, Sabino EC, Dinardo CL. Dezan MR, et al. Blood Cells Mol Dis. 2017 Jun;65:8-15. doi: 10.1016/j.bcmd.2017.03.014. Epub 2017 Mar 31. Blood Cells Mol Dis. 2017. PMID: 28388467
Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease.
Tozatto-Maio K, Girot R, Ly ID, Silva Pinto AC, Rocha V, Fernandes F, Diagne I, Benzerara Y, Dinardo CL, Soler JP, Kashima S, Araujo IL, Kenzey C, Fonseca GHH, Rodrigues ES, Volt F, Jarduli L, Ruggeri A, Mariaselvam C, Gualandro SFM, Rafii H, Cappelli B, Nogueira FM, Scigliuolo GM, Guerino-Cunha RL, Malmegrim KCR, Simões BP, Gluckman E, Tamouza R. Tozatto-Maio K, et al. Among authors: gualandro sfm. Front Immunol. 2020 Sep 4;11:2041. doi: 10.3389/fimmu.2020.02041. eCollection 2020. Front Immunol. 2020. PMID: 33013863 Free PMC article.
FcγR2B B2.4 haplotype predicts increased risk of red blood cell alloimmunization in sickle cell disease patients.
Costa Neto A, Santos F, Ribeiro I, Oliveira V, Dezan M, Kashima S, Covas D, Pereira A, Fonseca G, Moreira F, Krieger J, Gualandro S, Rocha V, Mendrone A Jr, Dinardo CL. Costa Neto A, et al. Among authors: gualandro s. Transfusion. 2020 Jul;60(7):1573-1578. doi: 10.1111/trf.15832. Epub 2020 May 4. Transfusion. 2020. PMID: 32681817 Clinical Trial.
42 results